Article Details
Retrieved on: 2024-08-08 14:27:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Total income stood at Rs 396 crore for the June quarter against Rs 303 crore in the year-ago period, AstraZeneca Pharma India said in a regulatory ...
Article found on: m.economictimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here